These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3013274)

  • 1. HTLV-III antibody and T-cell subset ratios in haemophiliacs and their spouses.
    McVerry BA; Machin SJ; Galloway MJ; McCarthy K; Evans P; Barnes RM; Turner GC; Cheingsong-Popov R; Tedder RS; Winter M
    Br J Haematol; 1986 Jun; 63(2):347-52. PubMed ID: 3013274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormalities of in vitro immunoglobulin production in apparently healthy haemophiliacs: relationship with alterations of T cell subsets and with HTLV-III seropositivity.
    Biagiotti R; Giudizi MG; Almerigogna F; Mazzetti M; Alessi A; Del Prete GF; Rafanelli D; Fiorilli M; Morfini M; Romagnani S
    Clin Exp Immunol; 1986 Feb; 63(2):354-8. PubMed ID: 3009063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HTLV-III seropositivity in European haemophiliacs exposed to Factor VIII concentrate imported from the USA.
    Melbye M; Froebel KS; Madhok R; Biggar RJ; Sarin PS; Stenbjerg S; Lowe GD; Forbes CD; Goedert JJ; Gallo RC
    Lancet; 1984 Dec; 2(8417-8418):1444-6. PubMed ID: 6151053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of antibodies to lymphadenopathy-AIDS virus in French haemophiliacs.
    Aymard JP; Janot C; Chermann JC; Montagnier L; Briquel ME; Legras B; Alexandre P; Streiff F
    Vox Sang; 1985; 49(2):161-3. PubMed ID: 2994302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of HTLV-III/LAV antibodies in Italian asymptomatic hemophiliacs given commercial concentrates of factors VIII and IX.
    Verani P; Mariani G; Mannucci PM; De Rossi G; Nicoletti L; Titti F; Falcione E; Pasqualetti D; Ammassari M; Gringeri A
    J Med Virol; 1986 Jun; 19(2):143-9. PubMed ID: 3014059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunological status of hemophiliacs: study of blood T-lymphocyte populations, serum immunoglobulins, and the prevalence of anti-LAV antibodies].
    Aymard JP; Janot C; Briquel ME; André E; Schooneman F; Vigneron C; Legras B; Alexandre P; Streiff F
    Pathol Biol (Paris); 1985 Dec; 33(10):951-6. PubMed ID: 3005949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human T-lymphotropic retrovirus type III/lymphadenopathy-associated virus antibody. Association with hemophiliacs' immune status and blood component usage.
    Jason J; McDougal JS; Holman RC; Stein SF; Lawrence DN; Nicholson JK; Dixon G; Doxey M; Evatt BL
    JAMA; 1985 Jun; 253(23):3409-15. PubMed ID: 2987559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HTLV-III status and abnormalities in T lymphocyte distribution in children with hemophilia A.
    Shannon BT; Roach J; Cheek-Luten M; Ruymann FB
    Diagn Immunol; 1986; 4(1):37-42. PubMed ID: 3006971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of human T lymphotropic virus type III antibodies to T lymphocyte subset abnormalities in hemophiliac patients.
    Hoxie JA; Rackowski JL; Cedarbaum AJ; Hurwitz S; Catalano PM
    Am J Med; 1986 Aug; 81(2):201-7. PubMed ID: 3017105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One year follow-up study of T-cell subsets and incidence of seropositivity for HTLV-I and HTLV-III antibodies in patients treated "on demand" or sporadically with clotting concentrates.
    Rodeghiero F; Castaman GC; Chisesi T; De Rossi A; Dalla Gassa O; Del Mistro A; Dini E; Castronovo S; Pornaro E; Chieco-Bianchi L
    Thromb Haemost; 1985 Oct; 54(3):665-8. PubMed ID: 3003954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of antibodies to LAV/HTLV-III in haemophiliacs treated with heat-treated factor VIII concentrate of American origin.
    Felding P; Nilsson IM; Hansson BG; Biberfeld G
    Lancet; 1985 Oct; 2(8459):832-3. PubMed ID: 2864551
    [No Abstract]   [Full Text] [Related]  

  • 12. Seroconversion for HTLV-III since 1980 in British haemophiliacs.
    Machin SJ; McVerry BA; Cheingsong-Popov R; Tedder RS
    Lancet; 1985 Feb; 1(8424):336. PubMed ID: 2857382
    [No Abstract]   [Full Text] [Related]  

  • 13. Absence of seroconversion for HTLV-III in haemophiliacs intensively treated with heat treated factor VIII concentrate.
    van der Meer J; Daenen S; van Imhoff GW; de Wolf JT; Halie MR
    Br Med J (Clin Res Ed); 1986 Apr; 292(6527):1049. PubMed ID: 3008906
    [No Abstract]   [Full Text] [Related]  

  • 14. HTLV-III seropositivity in symptom-free Italian haemophiliacs. Correlation with consumption of commercial concentrate and abnormalities of T and B lymphocytes.
    Giudizi MG; Biagiotti R; Almerigogna F; Mazzetti M; Alessi A; Massai G; Longo G; Scano G; Morfini M; Romagnani S
    Scand J Haematol; 1986 Feb; 36(2):198-202. PubMed ID: 2422735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A longitudinal study of patients with hemophilia: immunologic correlates of infection with HTLV-III/LAV and other viruses.
    Stein SF; Evatt BL; McDougal JS; Lawrence DN; Holman RC; Ramsey RB; Spira TJ
    Blood; 1985 Oct; 66(4):973-9. PubMed ID: 2994784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human T cell leukemia virus type III antibody, lymphadenopathy, and acquired immune deficiency syndrome in hemophiliac subjects. Results of a prospective study.
    Kreiss JK; Kitchen LW; Prince HE; Kasper CK; Goldstein AL; Naylor PH; Preble O; Stewart JA; Essex M
    Am J Med; 1986 Mar; 80(3):345-50. PubMed ID: 3006485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological alterations in anti-HTLV-III negative haemophiliacs and homosexual men in Hungary.
    Hollán SR; Füst G; Nagy K; Horváth A; Králl G; Verebélyi K; Ujhelyi E; Varga L; Mayer V
    Immunol Lett; 1985; 11(5-6):305-10. PubMed ID: 3005163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AIDS and haemophilia: morbidity and morality in a well defined population.
    Jones P; Hamilton PJ; Bird G; Fearns M; Oxley A; Tedder R; Cheingsong-Popov R; Codd A
    Br Med J (Clin Res Ed); 1985 Sep; 291(6497):695-9. PubMed ID: 2994801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of heat-treated clotting-factor concentrates in patients with haemophilia and a high exposure to HTLV-III.
    McGrath KM; Thomas KB; Herrington RW; Turner PJ; Taylor L; Ekert H; Schiff P; Gust ID
    Med J Aust; 1985 Jul; 143(1):11-3. PubMed ID: 2989666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency of the autologous mixed lymphocyte reaction in patients with classic hemophilia treated with commercial factor VIII concentrate. Correlation with T cell subset distribution, antibodies to lymphadenopathy-associated or human T lymphotropic virus, and analysis of the cellular basis of the deficiency.
    Smolen JS; Bettelheim P; Köller U; McDougal S; Graninger W; Luger TA; Knapp W; Lechner K
    J Clin Invest; 1985 Jun; 75(6):1828-34. PubMed ID: 2989334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.